Tarsus Pharmaceuticals share price logo

Tarsus Pharmaceuticals

NASDAQ: TARS

Mid Cap

$72.70

+1.21

(+1.69%)

as on

Tarsus Pharmaceuticals Stock Performance

as on August 22, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $71.26
    $73.14
    downward going graph

    1.98%

    Downside

    0.61%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $48.20
    $85.25
    downward going graph

    33.70%

    Downside

    17.26%

    Upside

    downward going graph

Tarsus Pharmaceuticals share price movements today

Previous Close
$71.49
Open
$71.26
Volume
681.7K
Market Cap
$3.0B
Day's Low - High
$71.26 - $73.14
52 Week Low - High
$48.20 - $85.25

Tarsus Pharmaceuticals Historical Returns

1 Month Return
+ 15.62 %
3 Month Return
+ 10.76 %
1 Year Return
+ 27.65 %
3 Year Return
+ 319.9 %
5 Year Return
+ 178.36 %

Tarsus Pharmaceuticals Stock Fundamentals & Key Indicators

Check Tarsus Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0B

EPS (TTM)

-1.09

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-63.19

Industry PE ratio

-13.046547619047619

PEG Ratio

-0.755183693077673

EBITDA

-35.2M

Revenue (TTM)

606.3M

Profit Margin

90.59%

Return On Equity TTM

-13.53%

Tarsus Pharmaceuticals Stock Valuation

Track how Tarsus Pharmaceuticals P/E has moved over time to understand its valuation trends.

Tarsus Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-51.50x)

December 31, 2025

Today (-51.50x)

December 31, 2025

Industry (-13.05x)

December 31, 2025

Highest (-4.38x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -51.50x

Tarsus Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tarsus Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.0B178.36%-63.1990.59%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Tarsus Pharmaceuticals Stock including INR - Dollar returns

The Tarsus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tarsus Pharmaceuticals investment value today

Current value as on today

₹1,47,000

Returns

₹47,000

(+47%)

Returns from Tarsus Pharmaceuticals Stock

₹34,108 (+34.11%)

Dollar Impact

₹12,892 (+12.89%)

Analyst Recommendation on Tarsus Pharmaceuticals Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Tarsus Pharmaceuticals. Average target price of $94.86

Tarsus Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Tarsus Pharmaceuticals.

What analysts predicted

23.36%UPSIDE

Target Price

$94.86

Current Price

$72.7

Analyzed by

8 Analysts

Target

$94.86

Tarsus Pharmaceuticals target price $94.86, a slight upside of 23.36% compared to current price of $72.7. According to 8 analysts rating.

Indian Investors' Interest in Tarsus Pharmaceuticals Stock

Search interest for Tarsus Pharmaceuticals Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Tarsus Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
27
40
48
66
78
102
118
151
162
173
Gross Profit
25
37
44
61
73
96
94
140
152
161
Operating Income
-37
-33
-25
-24
-26
-22
-14
-7
-6
-19
EBITDA
-34
-30
-20
-20
-22
-17
-12
-3
-6
-12
Interest Expense
0
2
2
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
1
Income Before Tax
-35
-33
-23
-23
-25
-20
-12
-6
-9
-15
Income Tax Expense
-
-
-
-
-
-
-
2
-2
2
Net Income
-35
-33
-23
-23
-25
-20
-12
-8
-6
-18
Net Profit Margin
94.01%
92.64%
93.26%
92.58%
93.35%
93.92%
79.28%
92.80%
94.20%
93.03%

Tarsus Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
57
25
17
182
451
Gross Profit
0
0
0
54
24
15
170
420
Operating Income
-1
-4
-26
-12
-62
-143
-120
-70
EBITDA
-1
-4
-26
-13
-59
-131
-106
-53
Interest Expense
-
0
0
-
2
3
7
8
Depreciation
0
0
0
0
0
0
1
1
Income Before Tax
-1
-4
-26
-13
-62
-135
-115
-64
Income Tax Expense
0
0
0
0
0
-
-
2
Net Income
-1
-4
-26
-13
-62
-135
-115
-66
Net Profit Margin
0.00%
0.00%
0.00%
96.36%
96.30%
90.87%
92.99%
93.20%

Tarsus Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-35
-33
-23
-23
-25
-20
-12
-8
-6
-18
Operating Cash Flow
-37
-14
-8
-22
-20
-29
18
19
-24
66
Investing Cash Flow
-102
-40
3
-59
-34
-51
-4
49
-58
37
Financing Cash Flow
108
42
0
2
136
1
2
2
1
3
Change in Cash
-31
-12
-4
-78
80
-79
16
70
-82
108

Tarsus Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-4
-26
-13
-62
-135
-115
-66
Operating Cash Flow
-1
-3
-21
3
-49
-117
-83
-12
Investing Cash Flow
0
0
0
0
-144
140
-199
-42
Financing Cash Flow
3
59
131
0
93
130
154
143
Change in Cash
2
55
110
3
-99
153
-127
88

Mutual Funds that own Tarsus Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Tarsus Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.913552%
1717384
IVY FUNDS
2.383198%
1045819
JANUS INVESTMENT FUND
1.685092%
739469
Prudential Jennison Small Co Fund, Inc.
0.990693%
434746
Fidelity Salem Street Trust
0.973258%
427095

Global Institutional Holdings in Tarsus Pharmaceuticals

Funds
Holdings
iShares
4.93%
Vanguard
4.86%
Richard Driehaus
2.11%
SPDR
0.67%
Invesco
0.53%

Insights on Tarsus Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TARS stock has moved up by 26.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 439.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 265.1%

About Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
OrganisationTarsus Pharmaceuticals
Headquarters17700 Laguna Canyon Road, Irvine, CA, United States, 92618
IndustryBiotechnology
CEODr. Bobak R. Azamian M.D.
E-voting on sharesClick here to vote

Key Management of Tarsus Pharmaceuticals

Name

Title

Dr. Bobak R. Azamian M.D.

Co-Founder, President, CEO & Chairman

Dr. Seshadri Neervannan Ph.D.

Chief Operating Officer

Dr. Bryan Wahl J.D., M.D.

General Counsel & Corporate Secretary

Mr. David Nakasone

Head of Investor Relations

Mr. Jeffrey S. Farrow CPA

CFO & Chief Strategy Officer

Ms. Adrienne Kemp

Vice President of Corporate Communications

Mr. Matthew Rossen M.B.A.

Vice President of Marketing

Mr. Scott Youmans

Vice President of Sales

Ms. Dianne C. Whitfield M.S.W.

Chief Human Resources Officer

Dr. Elizabeth Yeu-Lin M.D.

Chief Medical Officer

FAQs

What is Tarsus Pharmaceuticals share price today?

Tarsus Pharmaceuticals share price today is $72.70 as on at the close of the market. Tarsus Pharmaceuticals share today touched a day high of $73.14 and a low of $71.26.

What is the 52 week high and 52 week low for Tarsus Pharmaceuticals share?

Tarsus Pharmaceuticals share touched a 52 week high of $85.25 on and a 52 week low of $48.20 on . Tarsus Pharmaceuticals stock price today i.e. is closed at $72.70,which is 14.72% down from its 52 week high and 50.83% up from its 52 week low.

What is Tarsus Pharmaceuticals's market capitalisation today?

Tarsus Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Tarsus Pharmaceuticals Stock (TARS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tarsus Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tarsus Pharmaceuticals Shares that will get you 0.0206 shares as per Tarsus Pharmaceuticals share price of $72.70 per share as on August 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tarsus Pharmaceuticals Stock (TARS) from India?

Indian investors can start investing in Tarsus Pharmaceuticals (TARS) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in Tarsus Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Tarsus Pharmaceuticals share’s latest price of $72.70 as on August 22, 2026 at 8:46 am IST, you will get 0.1376 shares of Tarsus Pharmaceuticals. Learn more about fractional shares .

What are the returns that Tarsus Pharmaceuticals has given to Indian investors in the last 5 years?

Tarsus Pharmaceuticals stock has given 178.36% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?